BC
NUVB icon

Boxer Capital’s Nuvation Bio NUVB Stock Holding History

Boxer Capital’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-4,341,009
Closed -$14.1M – 79
2022
Q2 		$14.1M Hold
4,341,009
– – 0.89% 38
2022
Q1 		$22.8M Hold
4,341,009
– – 1.17% 25
2021
Q4 		$36.9M Hold
4,341,009
– – 1.43% 19
2021
Q3 		$43.1M Hold
4,341,009
– – 1.51% 18
2021
Q2 		$40.4M Hold
4,341,009
– – 1.43% 19
2021
Q1 		$45.4M Buy
4,341,009
+3,541,009
+443% +$39.6M 1.54% 17
2020
Q4 		$9.36M Hold
800,000
– – 0.3% 56
2020
Q3 		$8.96M Buy
+800,000
New +$8.64M 0.31% 55

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boxer Capital's NUVB Position: Q3 2022 in Review

Boxer Capital sold out of Nuvation Bio (NUVB) in Q3 2022, closing a stake of 4,341,009 shares — an estimated $14.1M sold.

Boxer Capital first reported a position in NUVB in Q3 2020 and held it in 8 quarters. The position peaked at $45.4M in Q1 2021. 121 funds tracked by Wall St. Rank hold NUVB as of Q3 2022.

  • Boxer Capital reported no remaining Nuvation Bio position as of Q3 2022 after selling out during the quarter.
  • Boxer Capital sold 4,341,009 Nuvation Bio shares in Q3 2022, an estimated $14.1M.
  • Boxer Capital first reported a position in Nuvation Bio in Q3 2020 and held it in 8 quarters.
  • Boxer Capital's Nuvation Bio position peaked at $45.4M in Q1 2021.
  • 121 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2022.

Based on Boxer Capital's 13F filing for Q3 2022, filed 14 Nov 2022.